-+ 0.00%
-+ 0.00%
-+ 0.00%
Kingsley Biotechnology (01548): Net trade sales of CARVYKTI® in the second quarter were approximately US$657 million
Share
Listen to the news

Zhitong Finance App News, Kingsley Biotech (01548) announced that according to the cooperation and licensing agreement between Legend and Janssen Biotech, Inc. (Janssen) on December 21, 2017, CARVYKTI® generated net trade sales of approximately US$657 million for the quarter ended June 30, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending